Aclaris Therapeutics
ACRS
ACRS
82 hedge funds and large institutions have $198M invested in Aclaris Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
44% more funds holding
Funds holding: 57 → 82 (+25)
14.59% more ownership
Funds ownership: 59.82% → 74.4% (+15%)
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
Holders
82
Holding in Top 10
3
Calls
$3.08M
Puts
$240K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$6.05M | |
| 3 | +$5.22M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$4.21M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.88M |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$1.98M | |
| 3 | -$1.62M | |
| 4 |
TI
Telemetry Investments
New York
|
-$1.43M |
| 5 |
Renaissance Technologies
New York
|
-$1.07M |